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Abstract During an inflammatory response, changes in
the adhesive properties of the endothelium occur that
enable normally non-adherent blood-borne leukocytes to
adhere and subsequently to traverse the endothelium
through small gaps at inter-cellular junctions. This review
concentrates on the role played by inter-endothelial
adhesion molecules during transmigration and the way
in which their expression may be regulated during
inflammation. We show that the final “open” signals that
lead to the formation of clefts between adjacent endothe-
lial cells may be derived from inflamed tissue underlying
the endothelium and from activated leukocytes.
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Introduction
Most of us living in the Western world take it for granted
that we will overcome an infection, with or without the
help of medical intervention. We do not doubt the fact
that cells of our immune system will leave their site of
production, migrate in the blood, and arrive ready and
rearing to go at exactly the spot where the infection
began. Nevertheless, the biology behind this so-called
inflammatory response is little short of a miracle. Our
vascular system is not an open-ended network of pipes
and channels that simply empty their contents into every
organ and tissue. Rather, circulating blood is contained
within a closed system, bound by endothelial cells whose
main purpose is to limit permeability and prevent the loss
of blood constituents and volume. The vascular endothe-
lium thus controls the passage of macromolecules and
leukocytes. In the resting state, the endothelium presents a
non-thrombogenic surface that is not permissive to the
passage of cells out of the bloodstream and into the
underlying tissues. During an inflammatory response,
however, changes in the adhesive properties of the
endothelium occur that enable normally non-adherent
blood-borne leukocytes to adhere and subsequently
traverse the endothelium through small gaps at inter-
cellular junctions. Precisely how these gaps form is a
complex issue. The focus of this review will be the role
played by inter-endothelial adhesion molecules during
transmigration and the way in which their expression may
be regulated during inflammation. We will try to show
that the final “open” signals that lead to the formation of
clefts between adjacent endothelial cells may be derived
from inflamed tissue underlying the endothelium and
from activated leukocytes.
Migration of cells of the immune system
The immune system protects the body from invading
microorganisms and parasites and surveys the tissues for
expression of aberrant self-antigens. The principal players
in this defense system are the leukocytes, and they are
well equipped to cope with virtually any pathogen. Most
pathogens have extremely high proliferation rates, and
prevention of systemic infections and damage needs a
rapid response from both innate and adaptive immune
systems. In other words, granulocytes, monocytes, and
lymphocytes have to migrate to the site of infection and
quickly. The mechanisms of innate immunity are always
present and can be rapidly mobilized as a first-line
defense against the infection. Innate immunity was
thought to represent a non-specific immune response,
but it is now clear that it has considerable specificity and
is capable of discriminating between pathogens and self.
Recognition of pathogens is mediated by germline-
encoded pattern-recognition receptors, including Toll-like
receptors in mammals (Akira et al. 2001). The cells of the
innate immune system may either deal successfully with
the infection or at least hold it in check while the more
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powerful forces of the adaptive immune response are
brought into play. The cells of the innate immune system
are produced rapidly and in large numbers when required
and generally have a short lifespan, being eliminated once
they have exerted their function. Their migration is
unidirectional, out of the bloodstream and across inflamed
endothelium. By contrast, the response of the adaptive
immune system, i.e., of the lymphocytes, is relatively
slow, since the number of cells with receptors specific for
any given pathogen is extremely low. Nature has
responded to this disadvantage in a remarkable way,
and lymphocytes have complex migration patterns. Ma-
ture non-activated lymphocytes continuously recirculate
between the blood and lymphoid tissues (Ager 1994;
Pabst and Binns 1989; Salmi and Jalkanen 1997; Wiedle
et al. 2001). Lymphocyte extravasation occurs in the post-
capillary venules at specialized vascular sites called high
endothelial venules (HEVs; Anderson and Anderson
1976; Anderson et al. 1976; Baekkevold et al. 2001;
Girard and Springer 1995). In humans, HEVs are found in
all secondary lymphoid organs, with the exception of the
spleen. Endothelial cells of HEVs have a specialized
morphology, together with the specific expression of
several genes that increase their adhesive properties for
lymphocytes (Girard et al. 1999). The recirculation of
naive lymphocytes has been the subject of many recent
reviews (Girard and Springer 1995; Salmi and Jalkanen
1997; Wiedle et al. 2001). Back to that trick of nature: if a
lymphocyte encounters its specific antigen in the second-
ary lymphoid organ, then its migration pattern changes.
This change is brought about by modifications in the
surface expression of adhesion molecules and chemokine
receptors that together re-direct the activated lymphocyte
to sites of inflammation, thereby maximizing the chances
that a primed lymphocyte will arrive at the site of
infection (for a review, see Muller 2002). Coupled with
this is the fact that lymphocytes that have been activated
by antigen are “harbored” as memory cells that can
respond more quickly to subsequent encounters with the
same antigen. The outcome is the generation of a pool of
antigen-specific lymphocytes that can quickly arrive at
the site of an infection and rapidly expand their numbers.
The multi-step adhesion cascade
In both inflammatory and homeostatic leukocyte migra-
tion, immune cells have to breach the vascular barrier, a
process often referred to as transmigration or extravasa-
tion or diapedesis. As mentioned above, constitutive
recirculation occurs essentially within lymph nodes across
HEVs; this will not be dealt with further here, except to
make the important point that HEVs represent a special-
ized endothelium. Their unique morphology has almost
certainly evolved to facilitate high lymphocyte traffic, a
hypothesis supported by the presence, in chronically
inflamed non-lymphoid tissues, of HEV-like vessels that
are believed to support lymphocyte recruitment (Dawson
et al. 1992; Duijvestijn et al. 1987). The nature of the
junctional composition of HEVs is not completely
understood, but it is tempting to speculate that there
may be similarities with inflamed endothelium. Outside
of the lymphoid organs, the endothelium changes in
response to an infection in the underlying tissue: a
normally non-permissive surface for the adhesion of
circulating leukocytes becomes permissive, supporting
the recruitment of high numbers of inflammatory cells
from the passing bloodstream. A multi-step adhesion
cascade has been proposed consisting of four steps
(Butcher and Picker 1996; Carlos and Harlan 1994;
Springer 1994). Transmigration represents the final step
in this cascade. In the first step, leukocytes roll on
endothelial cells. This is followed by a triggering step in
which there is a rapid activation of leukocyte integrins via
G-protein-coupled receptors, and then a third step at
which point the leukocyte adheres tightly onto the
endothelial surface. Finally, diapedesis occurs and the
leukocyte crawls through the junction between apposing
endothelial cells. An understanding of the first three steps
has proceeded rapidly over the past ten years.
Leukocyte rolling
The first step involves initial tethering of the leukocyte
followed by reversible rolling. Rolling is generally
mediated by interaction between selectins and glycosy-
lated ligands and leads to a slowing down of the cells in
the bloodstream. There are three selectins: L (leukocyte)-
selectin, P (platelet)-selectin and E (endothelial)-selectin.
L-selectin is expressed on virtually all non-activated
leukocytes, and the ligands for this selectin are constitu-
tively expressed on HEVs. Hence, this selectin is
responsible for the trafficking of naive lymphocytes
through lymph nodes (Berg et al. 1989). Upon activation
of lymphocytes by antigen, L-selectin is down-regulated,
and this prevents the re-entry of antigen-experienced cells
into lymph nodes (thus facilitating their re-direction to
sites of inflammation; Hafezi-Moghadam et al. 2001;
Rigby and Dailey 2000). The down-regulation of L-
selectin involves transcriptional regulation and protein
shedding by surface matrix metalloproteases (Preece et al.
1996). E-selectin and P-selectin are expressed on vascular
endothelium activated by inflammatory stimuli (Lasky
1995; Ley and Tedder 1995). E-selectin is up-regulated
by de novo protein synthesis and mediates the binding of
granulocytes and some lymphocytes to activated endo-
thelium. P-selectin is sorted to specialized granules
(Weibel-Palade bodies) and translocates to the cell
surface within minutes of stimulation by thrombin,
histamine, and complement components (Hattori et al.
1989; McEver et al. 1989), which are produced during an
inflammatory response. During chronic inflammation, P-
selectin may be expressed stably at the cell surface. The
rolling phase is not mediated exclusively by the selectins.
Notably, the integrin a4b1 (VLA-4) can support rolling
and tethering on vascular cell adhesion molecule-1
(VCAM-1), an integrin ligand expressed on activated
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endothelium (Alon et al. 1995; Berlin et al. 1995;
Henderson et al. 2001). In addition, CD44, a transmem-
brane glycoprotein expressed in a wide variety of cell
types, can function as an adhesion receptor to mediate
leukocyte rolling on hyaluronan (Clark et al. 1996;
DeGrendele et al. 1996), a component of the extracellular
matrix and a physiologic ligand of CD44 (Aruffo et al.
1990). Hyaluronan expression is upregulated on endothe-
lial cells following pro-inflammatory stimuli (Mo-
hamadzadeh et al. 1998; Nandi et al. 2000), and CD44
is upregulated in activated lymphocytes (DeGrendele et
al. 1997; Lesley et al. 1994). A recent report has
demonstrated that the cell surface density of CD44 is a
critical factor for CD44-dependent cell rolling on
hyaluronan (Gal et al. 2003).
Activation of integrins and tight adhesion
Rolling and tethering are reversible events and must be
replaced by a strong adhesion if the leukocyte is to cross
the endothelial barrier. In the second step of the adhesion
cascade, the leukocyte is stimulated by chemokines, some
of which are constitutively produced and appear to fulfil
housekeeping functions, but many of which are only
produced upon cell activation. For example, endothelial
cells exposed to bacterial products or primary inflamma-
tory cytokines, such as lipopolysaccharide (LPS), tumour
necrosis factor-a (TNF-a), or interleukin-1 (IL-1), pro-
duce monocyte chemotactic proteins (MCPs) (CCL7,
CCL8, CCL13), RANTES (CCL5), fractalkine (CX3CL1),
and macrophage inflammatory proteins (CCL3, CCL4)
(Baggiolini and Dahinden 1994; Ben-Baruch et al. 1995;
Mantovani et al. 1997, 1998). At least some chemokines
have been demonstrated to associate, through a heparin-
binding domain, with proteoglycans on the luminal surface
of endothelial cells (Tanaka et al. 1993). The effects of
chemokines on leukocytes are mediated by G-protein-
coupled receptors, and leukocyte responses to these
molecules depend on the presence of the relevant receptor.
Upon stimulation of a leukocyte through chemokine
receptors, the activity of its integrins is increased, and this
brings about the third step of the cascade, a tight adhesion
of the leukocyte onto integrin ligands on the endothelium.
Integrins are heterodimers formed by a combination of
one alpha and one beta chain (Shimizu et al. 1999). The
integrins a4b1 (VLA-4) and aLb2 (LFA-1) have major
functions in leukocyte-endothelial cell interactions (Hu et
al. 1993; R.S. Larson and Springer 1990; Lobb and
Hemler 1994; Stewart et al. 1995). The regulation of
integrin activity can be acheived in several ways: by a
change in integrin affinity (Ginsberg et al. 1992), by
association of the integrin with the cytoskeleton (Kucik et
al. 1996), or by clustering (van Kooyk et al. 1994).
Integrin ligands are members of the Ig superfamily;
intercellular cell adhesion molecule-1 (ICAM-1) and
ICAM-2 bind to LFA-1, VCAM binds to VLA-4.
ICAM-1 and VCAM are up-regulated on endothelium
stimulated by IL-1, TNF-a, and LPS (Dustin et al. 1986;
Wellicome et al. 1990).
Diapedesis
A picture of this final step in the adhesion cascade is just
beginning to take shape. Leukocytes transmigrate by
passing between adjacent endothelial cells, the paracel-
lular route. It should be noted, however, that this is not the
exclusive pathway for these cells. Early ultrastructural
studies suggested that lymphocytes could pass through the
body of an endothelial cell (Marchesi and Gowans 1964),
and recently, Feng and colleagues (1998) have demon-
strated that, under certain situations, in vivo neutrophils
emigrate from inflamed venules via a transcytotic path-
way, i.e., through the body of an endothelial cell. For
these studies, N-formyl-methionyl-leucyl-phenalanine
(FMLP) was injected as an inflammatory agent. Hence,
for at least one stimulus and one cell type, a transcytotic
pathway of extravasation exists. Whether other inflam-
matory cells take this route in response to different stimuli
remains, for the present, controversial. Furthermore, it
will be important to identify the molecules involved.
If the leukocyte adopts the paracellular route, and the
evidence to date suggests that much of the time it does,
then the challenge facing it is daunting, since endothelial
cells are connected to each other by an impressive array
of endothelial junctional structures that the leukocyte
must breach (for a review, see Johnson-Leger et al. 2000).
These junctions are present in order to maintain the
integrity of the endothelium and to regulate vascular
permeability. Four different types of endothelial junctions
have been described: tight junctions, gap junctions,
adherens junctions, and syndesmosomes, or complexus
adherentes, which are present to varying degrees along
the vascular tree (for reviews, see Dejana et al. 1995,
1996, 1997; Dejana and Del Maschio 1995; Vestweber
2000). These junctions resemble the homologous struc-
tures in epithelium, but their spatial organization is less
ordered, possibly reflecting the need for constantly
changing requirements of permeability and cellular
transmigration. The various junctions have been exten-
sively reviewed, and so their descriptions here will be
restricted to features that are important for understanding
the remainder of this review.
Inter-endothelial junctions
Tight junctions
These are the most apical junctions, i.e., closest to the
luminal surface, and they form a very close contact
between adjacent cells. They appear as a series of discrete
sites of apparent membrane fusion, involving the outer
leaflet of the plasma membranes of adjacent cells. Three
types of transmembrane proteins, occludin, claudins, and
junctional adhesion molecule (JAM), co-localize with
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tight junctions (Furuse et al. 1993, 1998; Martin-Padura et
al. 1998). Inside the cells, several cytoskeletal signaling
molecules are concentrated in the tight junctional area
(Gumbiner 1996).
Adherens junctions
These junctions are cellular membrane contacts formed
by transmembrane glycoproteins called cadherins. Cad-
herins physically attach the cell membrane to an
intracellular undercoat network of cytoplasmic proteins
and actin microfilaments via their cytoplasmic tails
(Geiger and Ayalon 1992; Tsukita et al. 1992), a process
mediated by intracellular catenins (Kemler 1993). In
addition to the neuronal cadherins, the endothelium
expresses a specific cadherin, VE-cadherin. VE-cadherin
is localized at intercellular junctions in all endothelia
(Ayalon et al. 1994; Lampugnani et al. 1992), and the
extracellular domain is responsible for Ca2+-dependent
homophilic adhesion. Like most other cadherins, the
cytoplasmic tail is linked to the cytoskeleton via the
catenins and p120 in the endothelium.
Historically, the adherens junction has been considered
a key player in endothelial permeability, and the VE-
cadherin:catenin complex has received and continues to
receive wide acclaim as the main regulator of permeabil-
ity in microvascular endothelium. This may be justified if
we consider permeability for macromolecules but it is
only part of the story concerning transmigration. Indeed,
the correlation between leukocyte transmigration and
changes in vascular permeability is far from clear. In the
following sections, we describe the junctional molecules
that play a role in transmigration, and the reader will
probably come to the conclusion, as we have, that the
assignment of a molecule to a particular junctional
structure does not determine its role in this process.
Indeed, with recent advances in our understanding of this
event, a picture is beginning to form of transmigration as
a dynamic process in which tight junctional, adherens,
and gap junctional proteins collaborate to bring about the
final step of the adhesion cascade across an inflamed
endothelium.
Gap junctions
Gap junctions are clusters of transmembrane hydrophilic
channels that allow direct exchange of ions and small
molecules (Beyer 1993). They consist of a pair of
interacting hemichannels (connexons), contributed by
each of the co-operating cells. Each channel comprises
six polypeptide subunits, or connexins, arranged around a
central pore. Three connexins are constitutively expressed
on vascular endothelium, connexin (Cx) 37, 40, and 43
(Bruzzone et al. 1993; Larson et al. 1997; Polacek et al.
1997; Reed et al. 1993; van Rijen et al. 1997). Interest-
ingly, the connexins on endothelial cells are mainly
located at cell-cell contacts (van Rijen et al. 1998).
Inflammation and the endothelium
When a tissue is damaged, it alerts the body’s defense
system in what has been termed the inflammatory
response. What is perceived as damage or injury may
be one or more of many factors: vessel occlusion leading
to hypoxia, physical damage, bacterial infection, or viral
infection. During infection, for example, extracellular
bacteria may stimulate tissue-resident macrophages to
produce a battery of cytokines and other inflammatory
mediators. Neutrophils are thereby recruited to the site of
infection and contribute to the inflammation, establishing
a self-perpetuating inflammatory response. The inflam-
matory response is itself composed of a series of different
events that involve soluble factors, changes in endothelial
cell adhesiveness and permeability, and recruitment of
inflammatory cells. A text-book definition of inflamma-
tion is the local accumulation of fluid accompanied by
swelling, reddening, and pain, all effects of which stem
from the dilation of local blood capillaries, a reduction in
blood flow rate, and increased permeability of the
endothelium. The changes that occur at the surface of
the endothelium “tag” the area as inflamed and act as
“exit” signals for circulating inflammatory cells, which
can now adhere to and transmigrate specifically at these
sites. If we consider these changes, we see that they
reflect, intriguingly, the requirements of each step of the
adhesion cascade. For example, early on during an
inflammatory response, histamine and thrombin are
released by mast cells present in damaged or infected
tissue. Both these agents trigger the rapid translocation of
P-selectin to the endothelial cell surface. E-selectin is up-
regulated by de novo protein synthesis following stimu-
lation by inflammatory cytokines (Doukas and Pober
1990; Leeuwenberg et al. 1990). Hence, the rolling and
tethering step is facilitated. Chemokines produced specif-
ically at the site of infection mediate the activation of
leukocyte integrins, whereas the ligands of these inte-
grins, ICAM-1 and VCAM-1 are up-regulated on the
surface of inflamed endothelium.
What about the final step of the adhesion cascade? Is
there a similar regulation of junctional proteins by
inflammatory signals? Diapedesis occurs at bi-cellular
junctions between two apposing endothelial cells at an
array of junctional complexes (for a review, see Muller
2001). The presence of these junctions might be expected
to hinder the passage of transmigrating cells, and indeed,
several studies have demonstrated that transmigrating
leukocytes may take the path of least resistance. Burns
and colleagues (1997, 2000) have demonstrated that
neutrophil transendothelial migration across monolayers
of human umbilical vein endothelial cells (HUVECs)
occurs preferentially at tri-cellular corners where the
borders of three endothelial cells intersect, and where
both tight and adherens junctions are discontinuous.
Furthermore, prior culturing of the HUVECs with astro-
cyte-conditioned medium (to induce a higher frequency of
tight junctions) does not affect neutrophil migration
across HUVEC monolayers (Burns et al. 1997). Since
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tri-cellular corners represent less than 10% of the total
endothelial border area, this implies that neutrophil
transmigration may be highly selective for tri-cellular
junctions. In the same study, monocytes showed less of a
preference for such junctions, and so tri-cellular migration
may be specific to neutrophils. For leukocytes that
“choose” the bi-cellular pathway, evidence is mounting
that they actually employ the junctional molecules to aid
their passage through the junctions. In this respect, we
should perhaps consider endothelial junctions not so
much as being fences, but more as representing bridges
where the molecules present enable the progression of the
leukocyte through the inter-endothelial cleft. In the
following section, we have detailed the molecules that
are present at these junctions and that have demonstrated
roles in transmigration and we discuss the way in which
their expression and localization may be influenced
during an inflammatory response.
Junctional molecules involved
in leukocyte transmigration:
regulation by inflammatory conditions
PECAM-1
PECAM-1, a member of the immunoglobulin superfamily,
is expressed diffusely on the surface of platelets and most
leukocytes (DeLisser et al. 1994; Watt et al. 1995). In
addition, it is concentrated at the intercellular junctions of
endothelial cells (although not associated with a particular
junctional structure), where it can support cell-cell adhe-
sion (Ayalon et al. 1994). PECAM has been implicated as
a critical mediator of monocyte and neutrophil
transendothelial migration in vivo, and also in vitro across
HUVEC monolayers (Bogen et al. 1994; Liao et al. 1997;
Muller et al. 1993). Whereas the absence of PECAM in
knockout mice does not affect the number of monocytes
undergoing transmigration, PECAM-deficient mice show
an accumulation of neutrophils at the basement membrane
of postcapillary venules in the mesentery, suggesting an
important role for this molecule in the migration of
neutrophils across the trans-basement membrane (Duncan
et al. 1999). Further support for this has come from a
recent study by Dangerfield and colleagues (2002) who
have demonstrated, by using intravital microscopy, that
homophilic PECAM-1 interactions induce the up-regula-
tion of integrin a6b1expression on transmigrated neutro-
phils, and that this interaction is required for neutrophil
migration through the perivascular basement membrane.
a6b1 is the principal leukocyte laminin receptor, and
laminin is a key component of all venular basement
membranes (Timpl 1989). The way in which inflamma-
tory signals impinge upon PECAM function is not yet
clear. The combined treatment of HUVECs with the
inflammatory cytokines TNF-a and interferon-g (IFN-g)
has been demonstrated to result in a re-distribution of
PECAM out of inter-cellular junctions; this is correlated
with changes in PECAM-cytoskeleton association (Romer
et al. 1995). One explanation for the removal of PECAM
from endothelial cell junctions during inflammation is that
its removal may reduce adhesive interactions between
adjacent endothelial cells, thus enhancing diapedesis.
Alternatively, or additionally, this re-distribution may
“free” junctional PECAM, thus providing a pool of
PECAM that can interact with transmigrating leukocytes.
Indeed, the recent findings of Mamdouh et al. (2003)
demonstrate that PECAM is actually targeted to areas of
transmigrating monocytes. Here, the authors demonstrate
the presence of a membrane network that lies just beneath
the surface of the plasma membrane at HUVEC cell
borders and that is connected to the junctional surface.
PECAM-1 is found in this compartment and constitutively
recycles evenly along endothelial cell borders. During
transendothelial migration across HUVEC monolayers,
however, recycling PECAM is targeted to areas of the
junction at which the migration of monocytes is taking
place. The authors suggest that this may provide a source
of endothelial PECAM for the leukocyte to engage via
homophilic interaction with its own PECAM. The contin-
uous addition of PECAM further and further into the
junction may create a haptotactic gradient through the
junction. Indeed, a role for PECAM as a molecular zipper
was first suggested 6 years ago (Bianchi et al. 1997), and
so the elucidation of a mechanism by which this may
occur is an exciting advance in our understanding of
transendothelial migration. Targeting of PECAM to
transmigrating cells would both provide a scaffold to
support the leukocyte through the endothelial cleft, and a
signal to prepare the cell for subsequent migration through
the basement membrane (Dangerfield et al. 2002).
CD99
Similar to PECAM-1, CD99 is concentrated at the borders
between endothelial cells and is a critical mediator of
monocyte transmigration in vitro through HUVEC mono-
layers (Schenkel et al. 2002). Again, similar to PECAM,
the blockade of CD99 on either the monocyte or the
endothelial cell prevents diapedesis, thus indicating the
homophilic interaction between leukocyte and endothelial
cell as playing a major part in monocyte transmigration.
CD99 appears to control a step in diapedesis distinct from
and distal to that controlled by PECAM-1 (Aurrand-Lions
et al. 2002; Schenkel et al. 2002). There is no evidence, to
date, that suggests that the localization or expression of
CD99 on endothelial cells may be regulated by inflam-
matory signals.
JAMs
As a brief introduction to the JAMs, the authors would
like to alert the reader to some confusion in the naming of
these molecules, which were cloned simultaneously by
independent laboratories. A table has been provided
(Table 1) listing the alternative names that have appeared
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for these molecules and including the officially accorded
nomenclature that will be henceforth adopted by the
scientific community (Muller 2003).
JAM-A
JAM-A was the first member of this “sub-family” of
adhesion molecules to be cloned (Martin-Padura et al.
1998). It belongs to the Ig superfamily, possessing two
extracellular Ig domains, and interacts homotypically in
confluent monolayers of Chinese hamster ovary (CHO)
cells. Confocal and immunoelectron microscopy has
shown that JAM-A co-distributes with tight junctional
components. Furthermore, several PDZ-containing pro-
teins have been demonstrated to associate with the PDZ-
binding motif in the cytoplasmic domain of JAM-A,
including cingulin, occludin, ZO-1, afadin, CASK, and
PAR-3/ASIP (Bazzoni et al. 2000; Ebnet et al. 2000,
2001). A monoclonal antibody directed against JAM-A
(BV11) inhibited spontaneous and chemokine-induced
monocyte migration across an endothelial cell monolayer
in vitro and monocyte infiltration in a model of skin
inflammation in vivo (Martin-Padura et al. 1998). Fur-
thermore, combined treatment with the inflammatory
cytokines TNF-a and IFN-g induced the disappearance
of JAM-A from intercellular junctions and its re-distribu-
tion on the cell surface, whereas the total amount of
surface JAM-A was unchanged (Ozaki et al. 1999). This
suggests a mechanism whereby the function of JAM-A
may be regulated during inflammation. Interestingly, such
combined cytokine treatment resulted in reduced
transendothelial migration under static conditions, al-
though there was no effect under flow conditions. The
real significance of these findings has only recently come
to light: Ostermann and colleagues (2002) have identified
LFA-1 as a ligand for JAM-A and have shown that JAM-
A-LFA-1 interaction is involved in the tight adhesion of
leukocytes (memory T cells) to HUVEC under static and
flow conditions, when the endothelial monolayer is
stimulated with TNF-a and IFN-g, i.e., when JAM-A is
expressed at the apical surface. On the other hand, when
JAM-A is in the junctions of unstimulated endothelial
cells, it apparently plays a role rather in the transmigration
of these cells. JAM-A has also been shown to contribute to
LFA-1-mediated transmigration of neutrophils across
unstimulated HUVEC under flow conditions. Interesting-
ly, the membrane proximal Ig domain of JAM-A supports
its interaction with LFA-1, whereas the membrane-distal
domain is responsible for its homophilic dimerization at
inter-endothelial junctions (Ostermann et al. 2002). We
should perhaps take a lesson from these studies, which add
a new level of complexity to the role played by junctional
molecules during leukocyte recruitment. Indeed, these
molecules may demonstrate a plasticity of function, being
involved for example in adhesion or diapedesis, depending
on their sub-cellular localization, and this localization may
itself be regulated by physiological parameters.
JAM-B and JAM-C
Two other JAM family members have since been cloned
(Arrate et al. 2001; Aurrand-Lions et al. 2000, 2001;
Cunningham et al. 2000; Palmeri et al. 2000). Like the
prototype, JAM-A, both have integrin ligands: a4b1 for
JAM-B, and aMb2 and aXb2 for JAM-C. Furthermore,
JAM-B and JAM-C appear to be binding partners. The
interaction between these two family members is intrigu-
ing, since JAM-B is expressed on HEVs of lymph nodes
and tonsils (Palmeri et al. 2000) and also on the
endothelium of arterioles in and around inflammatory
and tumour foci (Liang et al. 2002). JAM-C, in addition to
its expression on endothelium, is expressed on activated
T cells, platelets, B cells, monocytes, dendritic cells, and
NK cells in man (Johnson-Leger et al. 2002; Liang et al.
2002; Santoso et al. 2002). The role of these two JAMs in
transmigration is not yet clear. JAM-B/JAM-C interac-
tions may play a part in leukocyte trafficking during
inflammation. Nevertheless, the findings that JAM-C is
also expressed by the endothelium (Aurrand-Lions et al.
2001), and that both JAM-B and JAM-C have integrin
ligands on circulating cells, suggest that several interac-
tions may occur depending on the physiological setting.
Our laboratory has shown that murine lymphocytes, which
do not themselves express JAM-C, transmigrate endothe-
lial cells in a JAM-C-dependent manner (Johnson-Leger et
al. 2002). Furthermore, an antibody directed against JAM-
C inhibits the migration of human peripheral blood
mononuclear cells across monolayers of unstimulated
HUVECs in vitro. We do not yet know the mechanism(s)
involved in this antibody-mediated block, but clearly the
possibilities are manifold.
Table 1 Past and present des-
ignations of the JAM family of
proteins
Old names Reference Ligands New designation
JAM-1 Martin-Padura et al. 1998 JAM-A JAM-A
aLb2 (LFA-1)
JAM2 (man) Cunningham et al. 2000 a4b1 JAM-B
JAM-3 (mouse) Aurrand-Lions et al. 2000 JAM-C
VE-JAM (man) Palmeri et al. 2000
JAM3 (man) Arrate et al. 2001 JAM-C JAM-C
JAM-2 (mouse) Aurrand-Lions et al 2001 aMb2 (Mac-1)
aXb2
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Connexins
The last few reviews dealing with endothelial junctions
and leukocyte transmigration might have stated that gap
junctions appear to play no role during transmigration.
Given the experimental evidence or, more precisely, its
lack, this was a fair assessment of the situation. However,
recent data suggest that gap junctional coupling between
leukocytes and the endothelium may play a role in
modulating transendothelial migration (Zahler et al.
2003). Cx43 is expressed on stimulated leukocytes (Jara
et al. 1995), and human T, B, and NK lymphocytes
derived from peripheral blood and secondary lymphoid
organs express Cx40 and Cx43 (Oviedo-Orta et al. 2000).
Communication via gap junctions during transmigration
was first described by Oviedi-Orta and colleagues (2002).
In their study, the authors demonstrated, by using dye-
transfer experiments, that lymphocytes and endothelial
cells generate functional gap junction channels during
transmigration in vitro. More recently, Zahler et al. (2003)
have demonstrated that gap junctional coupling exists
between adherent neutrophils and HUVECs in vitro and
that this coupling is reduced when the HUVECs are
stimulated with TNF-a. More importantly, leukocyte
transmigration is enhanced when gap-junctional coupling
is inhibited, suggesting a regulatory role for this coupling
during transmigration.
Signalling at endothelial cell junctions
Whereas the precise details and sequence of events taking
place during transendothelial migration remain to be
determined, there is an overwhelming body of data in
support of paracellular migration. A paucity of data
describing transcytosis suggests that this pathway may
represent a minor one, perhaps being restricted to
particular cell subsets or stimuli. The scientific community
awaits clarification concerning this issue, which is an
interesting topic for future research. Our current view of
leukocyte emigration is, therefore, migration through a
cleft between apposing endothelial cells. Hence, the two
key aspects of this process are leukocyte migration and
endothelial junction widening. Cellular migration is the
result of choreographed changes in cell morphology and
adhesion properties and is regulated by the actin cyto-
skeleton. In a recent review that deals with molecular
events taking place within transmigrating leukocytes,
Worthylake and Burridge (2001) highlight the importance
of integrin activity and actin organization, which gives rise
to dramatic changes in cell shape and adhesive properties
in response to inflammatory signals. We should like to
spend the remainder of this current review by considering
how the widening of endothelial junctions may occur
during inflammation. To this end, we have come full circle
and will now consider the review’s title. By a “half-open
door” we do not wish the reader to imagine gaping holes
in the endothelium, to which the leukocyte merely has to
crawl and then slip through. Such a state of affairs would
have fairly catastrophic consequences for the organism,
since prolonged endothelial hyper-permeability is a seri-
ous and life-threatening clinical complication. Neverthe-
less, the evidence suggests that, during inflammation, the
endothelium of the post-capillary venules becomes locally
hyper-permeable, and that this is accompanied by the
formation of minute gaps between adjacent endothelial
cells. There is leakage of fluid from the blood, which
provides the underlying tissue with plasma proteins such
as complement factors, immunoglobulins, and coagulation
factors (for a review, see van Hinsbergh and van Nieuw
Amerongen 2002). In other words, the increase in
permeability is an attempt to “heal” the injured tissue.
Vasoactive agents such as histamine induce the formation
of these tiny gaps between endothelial cells (Baluk et al.
1997; Hirata et al. 1995). In vitro, histamine-induced
increases in permeability depend on an increase in
cytoplasmic calcium (van Hinsbergh and van Nieuw
Amerongen 2002). The increase in cytoplasmic calcium
ions causes a calcium-dependent activation of the myosin
light chain kinase (MLCK), an enzyme that phosphory-
lates myosin light chains. Phosphorylation of the myosin
light chain can induce actin polymerization and endothe-
lial cell retraction (Goeckeler and Wysolmerski 1995;
Moy et al. 1993, 1996; Sheldon et al. 1993), and this may
be sufficient to create the small gaps. Alternatively, agents
such as histamine may act directly on junctional proteins,
thereby regulating their presence in the junction. Hence,
under inflammatory conditions, gaps may form even in the
absence of leukocytes. In reality, these gaps are extremely
small (approximately 1.5 mm), probably too small to allow
the passage of leukocytes. However, it is conceivable that
leukocytes use these tiny “footholds” to begin engaging
the junction. Perhaps, via interaction with junctional
molecules, they actively participate in widening pre-
existing gaps, to just the right width to allow them to pass!
There is, indeed, experimental evidence to suggest that
leukocytes contribute to endothelial gap formation: stim-
ulated neutrophils induce myosin light chain phosphory-
lation via activation of MLCK and isometric tension in
endothelial cell monolayers, whereas unstimulated neu-
trophils have no effect on either parameter (Hixenbaugh et
al. 1997). What about other signals generated at inter-
endothelial junctions during inflammation? This is, as yet,
an area that awaits clarification. Nevertheless, if we
consider the proteins present in these junctions, it is
apparent that most, if not all, have recognized signaling
functions.
VE-cadherin
The endothelium specifically expresses VE-cadherin,
which is localized at intercellular junctions in all endo-
thelia and is linked to the cytoskeleton via b-catenin and
g-catenin. VE-cadherin is a target of agents that increase
vascular permeability, such as vascular endothelial
growth factor (VEGF), histamine, and thrombin (Esser
et al. 1998; Rabiet et al. 1994, 1996). The addition of an
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antibody against VE-cadherin to HUVEC monolayers
leads to a marked reorganization of the actin cytoskeleton
and increases monolayer permeability. In addition, neu-
trophil migration across HUVEC monolayers is enhanced
upon antibody treatment. These effects are accompanied
by a change in the distribution of VE-cadherin (Hordijk et
al. 1999). Furthermore, the in vivo administration of an
antibody directed against VE-cadherin resulted in in-
creased vascular permeability in the heart and lungs
(Corada et al. 1999). Esser and colleagues (1998) propose
that tyrosine phosphorylation of VE-cadherin regulates
vascular permeability. In an in vitro model, VEGF
stimulated the migration of endothelial cells and induced
an increase in the paracellular permeability of HUVECs.
These effects correlated with an increase in phosphoty-
rosine labeling at cell-cell contacts, and VE-cadherin, b-
catenin, g-catenin, and p120 were phosphorylated on
tyrosine. At the same time, there was a change in the
pattern of VE-cadherin staining from a continuous linear
labeling to a zigzag pattern, a change previously shown to
be correlated with the loss of junctional integrity. Allport
and colleagues (2000) have reported that VE-cadherin and
associated catenin molecules transiently disappear during
in vitro transmigration of monocytes. Real-time imaging
has since demonstrated, in vitro, that monocytes and
neutrophils migrate to endothelial cell-cell contacts
bearing continuous VE-cadherin staining. A gap is formed
in the VE-cadherin at the point at which the leukocyte
interacts with the endothelium, and the cell migrates
through this gap (Shaw et al. 2001). Indeed, the leuko-
cytes appear literally to “push aside” the VE-cadherin.
What is perhaps particularly interesting about this study is
that the leukocytes also migrated through small pre-
existing gaps in VE-cadherin staining, widening them
first in order to pass through them. In relation to this, it
should be noted that the HUVEC monolayers used for the
transmigration assays were stimulated with TNF-a. It
would be interesting to know whether such “pre-existing”
gaps were also present in unstimulated monolayers, or
whether this represents an inflammation-induced event.
VE-cadherin plays an essential role in the regulation of
endothelial cell contacts and is therefore likely to be a
target of signaling during transmigration. Furthermore, its
removal from areas where monocytes and neutrophils are
actively transmigrating is a strong argument for its
regulation being partially mediated by the leukocyte
itself. Whether this “pushing aside” involves the phos-
phorylation of VE-cadherin remains to be determined.
Vascular endothelial protein tyrosine phosphatase
(VE-PTP) and VE-cadherin have been recently demon-
strated to interact via their membrane proximal extracel-
lular domains (Nawroth et al. 2002). Furthermore,
induction of VE-PTP in CHO cells decreased the tyrosine
phosphorylation of VE-cadherin (probably via recruit-
ment and/or activation of another phosphatase) and, at the
same time, increased cell-contact integrity. Since VE-PTP
is a receptor-type phosphatase expressed at the surface of
endothelial cells, one might imagine a mechanism
whereby activated leukocytes bind to VE-PTP and
modulate its activity. Alternatively, or additionally, VE-
PTP may be regulated directly by inflammatory cytokines
acting locally on endothelial cells.
PECAM-1
PECAM-1 has two distinct immunoreceptor tyrosine-
based inhibitory motifs in its cytoplasmic domain (for a
review, see Newman and Newman 2003). Tyrosine
phosphorylated PECAM can recruit SH2 domain-con-
taining signaling proteins, notably SHP-2. PECAM-1 can
be phosphorylated on tyrosine in virtually all endothelial
cells following mechanical stimulation (Osawa et al.
1997) or cell adhesion (Bird et al. 1999). Src family
kinases appear to be involved in this phosphorylation,
although a non-Src family kinase may also play a role.
PECAM is also reported to interact with phosphorylated
b-catenin, and this interaction may link PECAM to the
actin cytoskeleton (Matsumura et al. 1997). g-Catenin
does not need to be phosphorylated to bind to PECAM.
Interestingly, the addition of anti-PECAM antibodies to
human NK cells results in actin rearrangements. Upon
stimulation with inflammatory cytokines, PECAM is re-
distributed away from endothelial junctions (Romer et al.
1995). Its subsequent engagement by PECAM expressed
on transmigrating cells may provide signals that induce
actin rearrangements in endothelial cells.
JAM-A
Upon activation of platelets by agonists such as thrombin
and collagen, JAM-A is phosphorylated by protein
kinase C. Furthermore, stimulation with thrombin leads
to phosphorylation of JAM-A on serine 284 (Ozaki et al.
2000), and this is correlated with a change in the
distribution of JAM-A, which subsequently forms clusters
at several sites of cell-cell contact. Whether a similar
mechanism operates in endothelial cells remains to be
determined. Certainly JAM-A is relocalized following
combined treatment of HUVECs with TNF and IFN-g
(Ozaki et al. 1999), although the signaling events
involved in this process await elucidation.
In summary, signals generated at endothelial cell
junctions may be derived from both inflammatory signals
and activated leukocytes, the combined effects of which
may serve to induce endothelial cell retraction and hence
gap widening.
Transmigration and changes in vascular permeability
As discussed above, changes in vascular permeability
occur during inflammation. If pre-existing minute gaps
are widened by transmigrating leukocytes, then we might
expect to see dramatic increases in permeability during
this event. However, there is no correlation between
transmigration and permeability changes. Some in vitro
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studies have demonstrated that vascular permeability does
increase during the migration of leukocytes toward
endothelial cell-cell contacts (Del Maschio et al. 1996;
Tinsley et al. 1999). Conversely, others have shown that
the migration of neutrophils through HUVEC monolayers
in response to chemoattractants does not induce any
change in electrical resistance or permeability for albumin
(Huang et al. 1988). Such discrepancies may arise from
the use of different leukocyte:endothelial cell ratios
(Huang et al. 1993), and from the comparison of
essentially different mechanisms such as adhesion and
transmigration. Indeed, when neutrophil adhesion was not
accompanied by transmigration, this led to an increase in
permeability, perhaps because there was no transmigrat-
ing cell to “plug” the gap induced by its adhesion (Huang
et al. 1993).
One mechanism by which “plugging” of endothelial
cell junctions may occur during transmigration is sug-
gested from the recent studies of Mamdouh and col-
leagues (2003). PECAM-bearing membrane is targeted to
areas of the junction at which monocytes are transmi-
grating, thereby increasing the contact area between
leukocytes and endothelial cells (Mamdouh et al. 2003).
This may serve to maintain the integrity of the endothe-
lium during transendothelial migration, thus preventing
leakage of plasma proteins (see commentary by Ager
2003). PECAM may turn out to be one of several
junctional molecules that are re-targeted to endothelial
surfaces contacting transmigrating leukocytes.
Platelets and inflammation
One aspect of inflammation that is sadly neglected in
many reviews dealing with the inflammatory recruitment
of leukocytes is the role played by platelets. This is
certainly a misguided omission since platelets undoubt-
edly play a very important role in leukocyte recruitment at
sites of inflammation. An intact endothelium normally
prevents platelet activation and adhesion, but upon
endothelial injury, sub-endothelial collagen and von
Willebrand factor become exposed, thereby supporting
platelet adhesion and activation (Fuster et al. 1992; van
Zanten et al. 1994). This leads to the recruitment of an
increasing number of platelets. Subsequently, interactions
occur between P-selectin expressed at the surface of
adhered activated platelets and PSGL-1 on circulating
leukocytes (Sako et al. 1993), and in this way, immobi-
lized platelets can capture leukocytes from flowing blood
(Hagberg et al. 1998; Lalor and Nash 1995). The initial
association leads to increased levels of the integrin Mac-1
on leukocytes (Neumann et al. 1999), further supporting
interactions with platelets. Platelets have been shown to
play an important role in the delivery of leukocytes to
endothelium (Diacovo et al. 1996a, 1998), and platelets
adherent to sub-endothelial matrix components support
the rolling, adhesion, and transmigration of leukocytes
(Diacovo et al. 1996b; Kuijper et al. 1997). Of particular
relevance to this review is the expression of PECAM-1
(Newman et al. 1990; Stockinger et al. 1990), JAM-A
(Malergue et al. 1998; Martin-Padura et al. 1998), and
JAM-C on platelets (Santoso et al. 2002). Since all these
molecules have demonstrated or proposed roles in
leukocyte migration across endothelial cells, it is con-
ceivable that leukocytes transmigrate monolayers of
activated platelets lining an injured endothelium by using
similar molecular interactions. In an exciting recent
“twist” to the tale, Mac-1 expressed on neutrophils and
monocytes has been identified as a ligand for platelet
JAM-C (Santoso et al. 2002). JAM-A has been demon-
strated to promote platelet aggregation (Kornecki et al.
1990; Naik et al. 1995), and interestingly, the stimulation
of platelets by thrombin induces a change in the
distribution of JAM-A, which forms clusters at several
sites of platelet-platelet contact.
Conclusions
Although a great deal of progress has been made in
understanding the final step of leukocyte emigration at
sites of inflammation, the molecular nature of the signals
and cross-talk that occur between a leukocyte and the
endothelium remain to be clarified. It is important to
remember that inflammation itself is very complex and
induces a wide variety of changes in the endothelium,
some of which are clearly independent of the leukocyte. It
would make biological sense if these early tissue-derived
signals primed the endothelium for later signals delivered
by adherent activated leukocytes—a true division of
labor. In this way, the task of the leukocyte becomes
much easier, and yet the barrier function of the endothe-
lium is preserved: the leukocyte may widen pre-existing
gaps in the endothelial monolayer and, at the same time,
Fig. 1 Leukocytes widen pre-
existing gaps in the endothelial
monolayer and, at the same
time, plug the gap as they pass
through the inter-endothelial
cleft
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plug the gap as it passes through the inter-endothelial cleft
(Fig. 1). The study by Mamdouh and colleagues (2003)
provides a novel mechanism by which the integrity of the
endothelium might be maintained during transendothelial
migration.
Whereas it is always intellectually appealing to
conceive a model in which each molecule in a biological
system plays a specific part and in a particular sequence
under a given set of conditions, we may have to accept
that transendothelial migration is, for the moment, too
complex to be explained by arrows and boxes. Undoubt-
edly, all the molecules described to date as playing a role
really do have a relevant function, but exactly which
molecules and which interactions predominate, and in
what sequence, during a cell’s journey from the apical
surface of the endothelium to its basement membrane is
just beginning to be unveiled. Real-time imaging, shear
flow experiments, and the use of fluorescently tagged
molecules, together with improved transfection protocols,
have made important contributions to these advances. To
understand precisely the nature of signals involved in
transendothelial migration necessitates the perfect in vitro
reconstruction of an inflammatory response. With the
speed of technological advances in biological research,
such a scenario may not be so far away.
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